SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Schnereger who wrote (1049)12/16/1996 10:15:00 AM
From: Linda Pacioretty   of 4342
 
Hi Everyone,

I took off for a wedding in Seattle early last Thursday, before the press release. Needless to say, I had alot of reading to do last night upon my return. It is refreshing that the members of this thread were able to read the press release and understand what it really means. Unfortunately, the financial community is a bit narrow minded and is unable to see the significance of this release. John and I are a bit tired of trying to defend Paracelsian for differing from the big pharamaceutical companies.

I feel that another overlooked item in the press release is the fact that the patients on Androvir experienced an increase in serum cholesterol. People suffering from AIDS have a lower than normal serum cholesterol which can be deterimental to an individual's health. How many other AIDS treatments can lower viral load and return the patient's body to a more normal state when used by itself? I don't want to get too defensive, but so many people forget that this is just the beginning.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News